In GBM, Bmi‐1 enhances self‐renewal and proliferation by repressing tumor suppressor genes and cell cycle inhibitors, such as p16, p19, and p21, to promote tumor cell undifferentiation [35, 42]. The gene discussed is CDKN2A; the disease is glioblastoma.